Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that microneedling combined with growth factors significantly improved blood circulation, hair thickness, strand resistance, and psychological well-being in patients with androgenetic alopecia, suggesting this combination as a promising and safe treatment option.

This study's review of existing literature suggests potential benefits of red LED photobiomodulation for treating telogen effluvium, but highlights a lack of standardized parameters and calls for further controlled trials.

This study reviews existing literature on regenerative therapy for androgenetic alopecia, highlighting that integrating growth factors, biotin, D-pantenol, and other active ingredients using the Vittahair protocol may enhance hair follicle regeneration, increase hair density, and improve hair quality, providing a precise and evidence-based treatment alternative.

In this study, researchers found significant neuropsychiatric complications from dengue infection, such as anxiety, depression, and even mania, during acute and recovery phases, linked to inflammatory responses and potential direct viral effects on the central nervous system.

In this narrative review, dysbiosis was found to potentially influence androgen metabolism and immune response, suggesting that gut microbiota balance may play a role in the prevention and treatment of androgenetic and areata alopecia.

This study observed that 30.4% of women at an American University clinic in Nicaragua were diagnosed with polycystic ovary syndrome, which is higher than international estimates of 8-13%.

This study found that polidioxanona threads increased hair density and satisfaction in treating various types of alopecia, with no adverse events reported, though the small sample limits broader conclusions.

This study developed a solid shampoo formulation with conditioning properties, highlighting its feasibility and environmental benefits compared to conventional shampoos due to biodegradable packaging and no water in its composition, thus offering a sustainable alternative in the cosmetic industry.

In this case study, researchers reported a 37-year-old woman with androgenetic alopecia and chronic telogen effluvium experienced significant hair growth improvement after personalized integrative treatment, including caffeine application, following a four-month protocol incorporating various therapies.

This integrative literature review found that hydroxychloroquine may stabilize inflammatory scarring autoimmune alopecias like frontal fibrosing alopecia, especially when combined with other therapies, while its effectiveness in non-scarring alopecias appears inconsistent and is limited to refractory cases.

This study evaluated the effects of pumpkin seed oil and rosemary essential oil combined with electrotherapy on androgenetic alopecia in stressed young women, finding no statistically significant differences between treatment groups and suggesting further research is needed to assess the oils' efficacy.

This study introduced an innovative antioxidant serum for skin care, using a lipid active from Rana catesbeiana Shaw, and validated its rejuvenating potential through physical-chemical and microbiological tests that ensured its antioxidant effectiveness, microbiological safety, and formulation stability.

This review examined the use of platelet-rich plasma in aesthetic skin rejuvenation and found promising results when combined with other treatments, but limited efficacy when used alone.

This integrative review found that triamcinolone hexacetonide remains the primary treatment for mild to moderate alopecia areata but noted its significant side effects with prolonged use, while emerging therapies like PRP and minoxidil offer promising alternative benefits with fewer risks.

In this study conducted on mouse fetuses, valproic acid was found to reduce Sonic Hedgehog expression in the skin and hair follicles, but the inclusion of vitamin E helped mitigate this effect, supporting its potential role in managing valproic acid-induced changes.

In this narrative review, researchers evaluated existing literature on the treatment of frontal fibrosing alopecia, finding that while no curative treatment exists, clinical improvements can be achieved through personalized and combined therapy approaches.

This article reviews a case of alopecia triangularis temporalis, emphasizing the need for histopathological confirmation to avoid misdiagnosis and highlighting surgical correction as the preferred treatment for confirmed cases.

In this case study, a 35-year-old man with recalcitrant folliculitis decalvans was successfully treated with Erbium-YAG laser, showing rapid improvement without hair loss, though further clinical studies are needed to define its benefits more comprehensively.

In this study, a literature review concluded that minoxidil is safe and effective for treating androgenetic alopecia, with few side effects, and highlighted the role of pharmacists in optimizing treatment by monitoring use and fostering adherence.

In this study, researchers investigated the use of the Pulse Booster Drug Delivery Mesojectgun technology for non-invasive treatment of scalp conditions, finding improvements in hair volume, thickness, and reduction of hair loss in four participants with alopecia after applying specific active ingredients.

This study describes the establishment of a hair clinic in Bogotá aimed at providing affordable hair restoration treatments for middle-income individuals, focusing on market, technical, administrative, and financial analyses to ensure business viability.

This article explores the evolution of scalp therapy in barbershops from a trend into a responsible practice, emphasizing the importance of clinical consistency and proposing a framework focused on client safety, documentation, and appropriate referrals to dermatology.

This study reviewed the etiology, mechanisms, and treatments of scarring alopecias and noted that early and accurate identification is crucial due to overlapping features among different types, making differential diagnosis challenging.

This study aimed to develop a dermocosmetic exfoliating formulation using babassu fibers for androgenetic alopecia treatment, but found that although the formulation met sensory standards, it was unstable in sunlight and heat, suggesting a need for optimization before commercialization.

This study reviewed the use of microinfusion of microparticles (MMP®) with methotrexate for treating alopecia frontal fibrosante and found it reduced symptoms associated with the condition and improved specific scalp measurements, showing that the technique is safe and well-tolerated.

This review of existing literature reports that photobiomodulation shows high effectiveness and safety in treating dermatological conditions like acne, psoriasis, and alopecia, though standardized clinical trials are needed to further validate its therapeutic benefits.

In this retrospective study, researchers found that baricitinib was effective for treating moderate to severe alopecia areata, with response rates in 24 patients comparable to existing real-world data, and no new safety concerns were identified.

In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.

In this case report, a 34-year-old man experienced temporary hair loss after undergoing an endovascular procedure with fluoroscopy for facial arteriovenous malformation, which resolved within two months following treatment with topical Minoxidil and oral Cilostazol.

This case report describes an infant with mucopolysaccharidosis type II who developed generalized hypertrichosis after receiving a bone marrow transplant and cyclosporine, highlighting the medication's potential role in exacerbating excessive hair growth and reviewing hypertrichosis causes.